(Q34330077)

1 August 2017

1 reference

title

Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies (English)

1 reference

1 August 2017

0 references

1 reference

Gordon SM

1

1 reference

1 August 2017

Avery RK

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Transplant Infectious Disease

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

161-167

1 reference

Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Infectious complications of lung transplantation. Impact of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Clinical aspects of fungal infection in organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Hypogammaglobulinemia in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Aspergillus endophthalmitis. An unrecognized endemic disease in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Aspergillus pericarditis with tamponade: report of a successfully treated case and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Vertebral Aspergillus osteomyelitis and acute diskitis in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Lung nodules and masses after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Invasive pulmonary aspergillosis: prediction at thin-section CT in patients with neutropenia--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Clinical presentation of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Role of open lung biopsy for diagnosis in lung transplant recipients: ten-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Diagnostic value of open lung biopsy in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Treatment of invasive aspergillosis with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Value of antigen detection in predicting invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

Standardized residual values for pulmonary gas transfer coefficient ( K CO): working party recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Aspergillus airway colonization and invasive disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Aspergillus infection in single and double lung transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990s

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Necrotizing choroiditis-retinitis as presenting symptom of disseminated aspergillosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Imaging of complications of lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

The pulmonary nodule after lung transplantation. Cause and outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Infection of the central nervous system in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Relapsing Aspergillus bronchitis in a double lung transplant patient, successfully treated with a new oral antimycotic agent

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Allergic bronchopulmonary aspergillosis in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Serodiagnosis and monitoring of Aspergillus infections after lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Pre-emptive therapy with azoles in lung transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Systemic availability of itraconazole in lung transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Low itraconazole serum concentrations following administration of itraconazole suspension to critically ill allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2001.003003161.X

7 January 2021

10.1034/J.1399-3062.2001.003003161.X

Identifiers

DOI

1 reference

1 August 2017

1 reference